Linklaters Americas reposted this
📢 A team led by Antonia Sherman, Annamaria Mangiaracina and Mark Daniel has advised Novo Holdings on the merger control, foreign investment and foreign subsidies aspects of its acquisition of Catalent Pharma Solutions, the largest healthcare buyout in 2024, valued at approximately US$16.5bn. The transaction was announced on 5 February 2024 and was subject to a number of merger control and foreign investment filings, as well as a foreign subsidies filing. Following the fulfilment of all regulatory conditions, the transaction closed on 18 December 2024. Read more on our website 👉 https://lnkd.in/dVkw2s-D
